(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 2.4% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.61%.
Treace Medical Concepts's revenue in 2026 is $212,690,000.On average, 7 Wall Street analysts forecast TMCI's revenue for 2026 to be $13,556,254,770, with the lowest TMCI revenue forecast at $12,976,232,053, and the highest TMCI revenue forecast at $14,018,722,771. On average, 7 Wall Street analysts forecast TMCI's revenue for 2027 to be $14,663,981,896, with the lowest TMCI revenue forecast at $13,545,920,289, and the highest TMCI revenue forecast at $16,439,574,824.
In 2028, TMCI is forecast to generate $14,823,520,439 in revenue, with the lowest revenue forecast at $14,242,205,912 and the highest revenue forecast at $15,259,506,334.